The Importance of an Unbiased Safety Review Board in Phase I Clinical Trials
DOI:
https://doi.org/10.17140/CTPOJ-6-e002Abstract
Conducting clinical trials is the process that biopharmaceutical companies must use to demonstrate that their product is safe, well-tolerated, and efficacious to obtain marketing approval from the Food and Drug Administration (FDA).1 Human clinical trials are initiated after preclinical trials have demonstrated sufficient safety data. At that point, the FDA will allow these trials to begin on normal healthy volunteers. However, if the FDA considers the risks too high for these volunteers, the agency will require the specific disease population to be studied. For example, the associated adverse effects of many oncology drugs frequently place them into a riskier category, and ethically it would be inappropriate to expose healthy volunteers to these medications. Since many adverse effects
of a drug are not yet known during a Phase I study, they carry an inherent risk to the participants.
References
National Cancer Institute (NCI). What are clinical trials? 2020. Website. https://www.cancer.gov/about-cancer/treatment/clini-cal-trials/what-are-trials. Accessed May 4, 2023.
Joffe S, Miller FG. Rethinking risk-benefit assessment for phase I cancer trials. J Clin Oncol. 2006; 24(19): 2987-2990. doi: 10.1200/ JCO.2005.04.9296
European Medicines Agency (EMA). Guideline on data mon-itoring committees. 2016. Website. https://www.ema.europa. eu/en/documents/scientific-guideline/guideline-data-monitor-ing-committees_en.pdf. Accessed May 4, 2023.
National Institutes of Health (NIH). Data and safety moni-toring board guidelines. 2018. Website. https://www.nidcr.nih. gov/research/human-subjects-research/toolkit-and-educa-tion-materials/interventional-studies/data-and-safety-monitor-ing-board-guidelines. Accessed May 4, 2023.
U.S. Food and Drug Administration (FDA). Guidance for clini-cal trial sponsors: Establishment and operation of clinical trial data monitoring committees. 2019. Website. https://www.fda.gov/ regulatory-information/search-fda-guidance-documents/estab-lishment-and-operation-clinical-trial-data-monitoring-committees. Accessed May 4, 2023.
National Cancer Institute (NCI). Safety monitoring in clinical trials. 2021. Website. https://deainfo.nci.nih.gov/grantspolicies/ datasafety.pdf. Accessed May 4, 2023.
Auerbach AD, Landefeld S, Shojania KG. The tension between needing to improve care and knowing how to do it. N Engl J Med. 2007; 357: 608-613. doi: 10.1056/NEJMsb070738
Thompson DF. Understanding financial conflicts of interest. In: Research Ethics. England, UK: Routledge Publisher; 2017: 505-508. doi: 10.4324/9781315244426-56 Editorial | Volume 6 | Number 1 |
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Clinical Trials and Practice – Open Journal (CTP) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
